Medicamentos com defeitos estão entre nós! Umaanálise do combate aos defeitos em embalagens demedicamentos à luz do Direito Administrativo Sanitárioe do Consumidor

Author:

Figueredo AlexandreORCID,Macedo Elizabeth ValverdeORCID,Costa Jorge Carlos Santos daORCID

Abstract

Introduction: Providing quality, safe, and effective medicine is the purpose of the production and supply chain; however, errors happen. This work addresses action against defects observed in medicines’ primary and secondary packaging from the perspective of health and consumer administrative legislation and their practical consequences in the consumer relationship. Objective: To demonstrate the contribution of health and consumer administrative legislation, with emphasis on Good Manufacturing Practices (GMP) for medicines and the Consumer Protection Code, ensuring adequate and safe information to patients and how suppliers and consumers can influence the control of defects and safe administration of medicines, before, during, and after sale. Method: Adoption of descriptive and explanatory research, a documental nature bibliographical using checklist for direct observation register, about a qualitative and quantitative approach. Results: It was identified that current resolution about GMP applied at medicines have 34 control mechanisms that contribute to avoiding defects in packaging operations, an advance for patient safety. In addition, in all legislative frameworks analyzed, there was a protection of consumerist principles of transparency in information, objective good faith and security. However, there were gaps in the use and knowledge of information and safety devices in packaging materials. Highlighting the practice of changing medications without regulatory provisions as a problem for communicating product defects to the manufacturer and increasing health risk. Conclusions: Despite legislative evolution to combat defects, consumers and pharmacies need more knowledge, awareness, and adequate use of complaint channels. The return/exchange of medicines is a potential sanitary risk that needs to be confronted and perhaps better regulated.

Publisher

Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3